SE9302013L - Method for determining HbA 1C and composition for carrying out the process - Google Patents

Method for determining HbA 1C and composition for carrying out the process

Info

Publication number
SE9302013L
SE9302013L SE9302013A SE9302013A SE9302013L SE 9302013 L SE9302013 L SE 9302013L SE 9302013 A SE9302013 A SE 9302013A SE 9302013 A SE9302013 A SE 9302013A SE 9302013 L SE9302013 L SE 9302013L
Authority
SE
Sweden
Prior art keywords
composition
carrying
determining
blood
dried
Prior art date
Application number
SE9302013A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE504914C2 (en
SE9302013D0 (en
Inventor
Jan O Jeppsson
Original Assignee
Boehringer Mannheim Scandinavi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Scandinavi filed Critical Boehringer Mannheim Scandinavi
Priority to SE9302013A priority Critical patent/SE504914C2/en
Publication of SE9302013D0 publication Critical patent/SE9302013D0/en
Priority to AU70123/94A priority patent/AU7012394A/en
Priority to PCT/SE1994/000564 priority patent/WO1994029730A1/en
Publication of SE9302013L publication Critical patent/SE9302013L/en
Publication of SE504914C2 publication Critical patent/SE504914C2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin

Abstract

A method for determining the HbA1c content in blood which is dried in an absorbing material is disclosed. The dried blood is treated with a cysteine solution for eliminating the interfering HbA3 fraction and reducing the amount of methaemoglobin, whereupon the HbA1c content is determined. According to one embodiment, the absorbing material with the dried blood is pretreated with a buffer solution. A composition for the treatment is also disclosed. The composition comprises a buffered cysteine solution.
SE9302013A 1993-06-11 1993-06-11 Method for determining HbA1C and composition for carrying out the process SE504914C2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9302013A SE504914C2 (en) 1993-06-11 1993-06-11 Method for determining HbA1C and composition for carrying out the process
AU70123/94A AU7012394A (en) 1993-06-11 1994-06-10 Method for determining hba1c, and composition for implementing the method
PCT/SE1994/000564 WO1994029730A1 (en) 1993-06-11 1994-06-10 METHOD FOR DETERMINING HbA1c, AND COMPOSITION FOR IMPLEMENTING THE METHOD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302013A SE504914C2 (en) 1993-06-11 1993-06-11 Method for determining HbA1C and composition for carrying out the process

Publications (3)

Publication Number Publication Date
SE9302013D0 SE9302013D0 (en) 1993-06-11
SE9302013L true SE9302013L (en) 1994-12-12
SE504914C2 SE504914C2 (en) 1997-05-26

Family

ID=20390247

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302013A SE504914C2 (en) 1993-06-11 1993-06-11 Method for determining HbA1C and composition for carrying out the process

Country Status (3)

Country Link
AU (1) AU7012394A (en)
SE (1) SE504914C2 (en)
WO (1) WO1994029730A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE444491T1 (en) 2005-05-20 2009-10-15 Germediq Forsch & Entw Ges Mbh METHOD FOR DETERMINING CARDIOVASCULAR RISK FACTORS
CN106033076A (en) * 2015-03-18 2016-10-19 杭州量康科技有限公司 Method and system for detecting dried blood sample

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments

Also Published As

Publication number Publication date
SE504914C2 (en) 1997-05-26
WO1994029730A1 (en) 1994-12-22
SE9302013D0 (en) 1993-06-11
AU7012394A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
DE69434497D1 (en) USE OF ALPHA-1,4-GLUCANLYASE FOR THE PREPARATION OF 1,5 D-ANHYDROFRUCTOSE
ATE223044T1 (en) DETECTION OF RETICULOCYTES WITH CORIPHOSPHIN O
EE9700225A (en) A method of treating diabetes mellitus using KKF
DK97189A (en) immobilization
EA199900725A1 (en) SYNERGETIC COMBINATIONS OF SULFONILM URINE AND GLITAZONE IN THE TREATMENT OF DIABETES
SE8802781D0 (en) GAS DEHIBITION PROCEDURE
DE3172043D1 (en) Derivatized agarose and method of making and using same
DE68923556D1 (en) ACID-SENSITIVE SUB-UNIT OF AN INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN COMPLEX.
NO902833D0 (en) OXIDATIVE DENATURING OF PROTEIN ANALYSTS.
KR940027658A (en) Thrombin binding material and preparation method thereof
SE9302013L (en) Method for determining HbA 1C and composition for carrying out the process
IT7823336A0 (en) COMPOSITION SUITABLE FOR REDUCING THE PHENYLALANINE CONTENT AND METHOD USING THE SAME.
DK0509980T3 (en) Process for, in particular, accelerated aerobic microbiological degradation of biological materials
ATE124539T1 (en) IMMUNOGEN AND ITS USE FOR OBTAINING ANTIBODIES AGAINST HBA1C.
AU582060B2 (en) Process for reducing turbidity in control sera
EP0359281A3 (en) Silver staining technique and kit
ES2110998T3 (en) PROCEDURE FOR THE DETERMINATION OF THROMBOPENIAS.
PT1171578E (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING NKT CELLS ACTIVATED BY PIM AND ITS USE IN THERAPY
AR227320A1 (en) AN APPROPRIATE COMPOSITION FOR USE IN THE TREATMENT OF GLASS FIBERS, METHOD FOR TREATING SUCH FIBERS WITH THE ABOVE COMPOSITION, TREATED GLASS FIBERS, AND COMPOSITE BODY CONTAINING SUCH FIBERS
JPS6426520A (en) Stabilization of cell membrane and application to prevervation of cell in state protecting essence of antibody of cell membrane surface
ES2061827T3 (en) ADHESIVE COMPONENT FOR THE TREATMENT OF MATERIALS WITH COLLAGEN CONTENT.
ES2039250T3 (en) WOOL MATERIALS TREATMENT.
EP2172227A3 (en) Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby
ATE196510T1 (en) USE OF AN OSMOLYTE TO REDUCE OR REMOVE NON-COVALENT BONDING OF BIOLOGICAL MOLECULES TO INERT SURFACES
ES435589A1 (en) A procedure for treating discontinuous cellulose fiber with plastic and lubricant polymer. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9302013-9

Format of ref document f/p: F